TY - JOUR T1 - Clinical Outcomes of Fully Covered Self-expanding Metallic Stent Placement for Palliation of Incurable Esophageal Cancer With or Without Radiotherapy JF - Anticancer Research JO - Anticancer Res SP - 385 LP - 389 DO - 10.21873/anticanres.14787 VL - 41 IS - 1 AU - KEN SASAKI AU - YUSAKU OSAKO AU - MASAKAZU URATA AU - MASAHIRO NODA AU - YUSUKE TSURUDA AU - YASUTO UCHIKADO AU - ITARU OMOTO AU - YOSHIAKI KITA AU - DAISUKE MATSUSHITA AU - KEISHI OKUBO AU - TAKAAKI ARIGAMI AU - SHINICHIRO MORI AU - HIROSHI KURAHARA AU - SHOJI NATSUGOE AU - TAKAO OHTSUKA Y1 - 2021/01/01 UR - http://ar.iiarjournals.org/content/41/1/385.abstract N2 - Background/Aim: A combination therapy of esophageal stent and chemoradiotherapy (CRT) is currently considered risky for severe complications. The aim of this study was to assess the safety and efficacy of a fully covered self-expandable metallic stent (FCSEMS) placement in palliating incurable esophageal cancer before and/or after CRT. Patients and Methods: We retrospectively reviewed clinical outcomes of 64 incurable advanced esophageal cancer patients with FCSEMS placement. Forty-two of 64 patients had FCSEMS placement with RT. Results: The rate of all of stent-related complications tended to be higher in patients who had RT, although no significant difference was observed. The stent-related deaths occurred in one patient due to hemorrhage after FCSEMS placement in the RT-negative group. Conclusion: Palliation of dysphagia or fistulas with FCSEMS in patients with incurable esophageal cancer before and/or after RT is not associated with an increased risk of life-threatening complications. ER -